Maison Solutions Inc.
MSSAbout the company
Maison Solutions Inc., together with its subsidiaries, operates as a specialty grocery retailer in the United States. The company offers perishable products, such as meat, seafood, vegetables, and fruit; non-perishable products, including grocery products comprising cooking utensils, canned foods, Chinese and Asian seasonings and spices, and snacks, as well as liquor, cigarette, lottery, newspaper, reusable bag, non-food, and health products; and general merchandise, beauty care, pharmacy, and other items and services in its stores. It serves its products online.
Investment snapshot
Positive
2
BUY / PASS
Neutral / negative
3 / 11
NEUTRAL / FAIL
Median fair value
$1.32
+44.6% vs price
Models with upside
3 / 17
Positive margin of safety
Strongest signal
MSS undervalued: all 3 models price fair value above $0.91 (median $1.32)
Key risk
No clean pass — all 8 investors flag at least one growth criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | Not ranked | BUY | FAIL | NEUTRAL | NEUTRAL | FAIL | FAIL | FAIL | FAIL | PASS | FAIL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| Margin of Safety | +10.5% | N/A | N/A | N/A | N/A | N/A | N/A | +53.9% | +30.8% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-01-31 · Balance sheet at 2026-01-31 · Annual history · FY 2024 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 · TTM ended 2026-01-31 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 · Balance sheet at 2026-01-31 · TTM ended 2026-01-31 vs 2025-01-31 · TTM ended 2026-01-31 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | TTM ended 2026-01-31 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-14 Score computed: 2026-11-14 | Annual history · FY 2024 · TTM ended 2026-01-31 · Balance sheet at 2026-01-31 · Market data at 2026-11-01 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 · TTM ended 2026-01-31 · Balance sheet at 2026-01-31 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-08-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment · Balance sheet at 2026-01-31 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 · TTM ended 2026-01-31 · Qualitative assessment Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 · TTM ended 2026-01-31 · Balance sheet at 2026-01-31 · Market data at 2026-11-01 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-01-31 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-08-14 Score computed: 2026-11-14 | TTM ended 2026-01-31 · Balance sheet at 2026-01-31 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2024 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-08-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Balance sheet at 2026-01-31 Latest source filing: 2026-03-17 Score computed: 2026-11-14 | TTM ended 2026-01-31 · Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-03-17 Score computed: 2026-11-14 |
Where It Passes
- Valuation models100% pass✓ 3▾
MSS undervalued: all 3 models price fair value above $0.91 (median $1.32)
Graham fair value$1.02✓Graham+10.5% margin vs $0.91Pabrai fair value$1.98✓Pabrai+53.9% margin vs $0.91Akre fair value$1.32✓Akre+30.8% margin vs $0.91 - Cash Flow60% pass✓ 7✗ 5▾
6 of 10 pass — Lynch, Ackman, Neff +1 more object
Free Cash Flow Proxy$1.5M✓BuffettPositive and growingFCF Positive and Growing$0.4M✗LynchPositive and growingOperating Cash Flow$4.8M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=6.15%, ROA=1.51%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)3.4x✓Dreman< 8xP/E or FCF YieldP/E=13.0x✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive2/2 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap✗Ackman>= 4%Price / FCF per Share✗Ackman<= 25Positive Operating Cash Flow frequency3/4 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Growth0% pass✓ 3✗ 10▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 13.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -47.2% vs Rev: 1.8%✓LynchInventory growth < Revenue growthEPS Growth Direction$-0.04 (2021) -> $0.07 (2024)✓DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency3/4 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth32.0%✓Ackman>= 5%Positive EPS Growth Frequency2/3 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 22.5% -> 21.2%, operating margin 0.2% -> -1.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Efficiency13% pass✓ 2✗ 9▾
7 of 8 flag MSS's efficiency — Graham, Buffett, Greenblatt +4 more
Current Ratio0.67✗Graham>= 2.0ROIC (3-5 yr avg)-14.3%✗Buffett> 10%ROIC - WACC-24.3%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)✗Greenblatt> 25%Current Ratio Change YoY0.49 -> 0.57✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.70x -> 1.61x✓PiotroskiImproved YoYCurrent Assets / Current Liabilities0.67✗Dreman> 1.5Return on Invested Capital-66.7%✗Munger> 15%ROIC (high and growing)FY2022: ROIC=1.9%; FY2023: ROIC=-16.4%; FY2024: ROIC=-5.8%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC-5.8% (RR=100% x ROIC=-5.8%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/4 years above 12% (latest -5.8%)✗SleepROIC > 12% in a majority of years - Valuation15% pass✓ 9✗ 19▾
11 of 13 flag MSS's valuation — Graham, Lynch, Greenblatt +8 more
Price / Book Value per Share1.4x✗Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio1.4x✓Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 13.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value-469.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-469.0%, ROC=N/A (invested capital <= 0)✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS13.0x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)3.4x✓Dreman< 8xValuation ReasonablenessP/E=13.0x, OE Yield=13.6%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=13.0x✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=13.0x, P/B=1.4x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per Share✗Ackman<= 25Price vs. Trailing Low126% of trailing low ($0.73)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-1512.07%; #6115/6340 (top 96.5%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+9.6984; #190/6449 (top 2.9%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS13.0x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per ShareN/A (non-positive TBVPS)✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+143.1752; #70/5247 (top 1.3%)✓OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+25.67%; #1148/6202 (top 18.5%)✗OshaughnessyTop 10% of eligible cross-section - Verdicts15% pass✓ 2✗ 11▾
Split decision: 11 FAIL · 3 NEUTRAL · 1 BUY · 1 PASS
Overall verdict✗GrahamFAIL (2/9)✗BuffettFAIL (2/9)✗LynchFAIL (1/7)•GreenblattNot ranked✓PiotroskiBUY (F-Score 8)✗DremanFAIL (3/11)•MungerNEUTRAL (3/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)✗MarksFAIL (2/5)✗AckmanFAIL (2/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #1965/2370 (Top 82.9%))✗NeffFAIL (2/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked) - Profitability19% pass✓ 8✗ 27▾
13 of 16 flag MSS's profitability — Graham, Buffett, Lynch +10 more
Positive EPS (10 years)2/5 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)3/5 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)72.3%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)-1.0% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$1.5M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 13.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE-155.9%✗Lynch> 15%EBIT / Enterprise Value-469.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-469.0%, ROC=N/A (invested capital <= 0)✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets1.51%✓PiotroskiROA > 0ROA Change YoY-4.05% -> 1.51% (delta: +5.57%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=6.15%, ROA=1.51%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY20.0% -> 21.2%✓PiotroskiImproved YoYPre-Tax Income / Revenue-10.9%✗Dreman>= 8%Net Income / Shareholders' Equity-155.9%✗Dreman> 12%Margin of SafetyP/E=13.0x, P/B=1.4x✓PabraiP/B < 1.5 or P/E < 15Return on Equity72.3% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency3/4 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue-7.6%✗Ackman>= 15%Net Income / Shareholders Equity-155.9%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend0.2% (2022) -> -1.0% (2024)✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 22.5% -> 21.2%, operating margin 0.2% -> -1.0%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-1512.07%; #6115/6340 (top 96.5%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+31.82%; #1329/3702 (top 35.9%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity-155.91%; #4787/5226 (top 91.6%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0295; #1891/5884 (top 32.1%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Debt & Leverage25% pass✓ 5✗ 10▾
9 of 12 flag MSS's debt & leverage — Graham, Buffett, Lynch +6 more
Debt Levels0.33✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3LT Debt vs Net Current AssetsLT Debt $2.6M vs NCA $-6.2M✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.33, IC: -3.8x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.33✗Lynch< 0.33Cash - Long-term Debt$-1.1M✗LynchPositive preferredLT Debt / Total Assets Change3.11% -> 3.38%✗PiotroskiDecreased YoYCurrent Assets / Current Liabilities0.67✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.33✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xInterest Coverage & Debt/EBITDAIC=-3.8x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.33✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.3342; #2099/4210 (top 49.9%)✗AsnessTop 30% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Retired 0.9% of shares last year, 10.9% issued over two.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-01-31 2025-02-01 – 2026-01-31 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization. | Q3 FY 2026 2025-11-01 – 2026-01-31 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization. | Q2 FY 2026 2025-08-01 – 2025-10-31 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization. | Q1 FY 2026 2025-05-01 – 2025-07-31 Sources | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
| FY 2020Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $794.4Kcurrent | -- | -- | -- | $19.5Mest. | $16.0Mest. | $89.6Mest. | -- | -- |
| Revenue | $113.7M↑2% | $29.5M↓13% | $27.6M↓11% | $27.2M↓8% | $124.2M↑114% | $58.0M↑5% | $55.4M↑32% | $42.0M | -- |
| Operating Income | -$8.7M↓979% | -$2.8M↓353% | -$1.4M↓302% | $184.2K↓89% | -$1.3M↑53% | -$2.7M↓3333% | $83.6K↑110% | -$826.6K | -- |
| Net Income | -$12.0M↓809% | -$5.2M↓615% | -$5.0M↓1840% | -$1.5M↓320% | $1.2M↑135% | -$3.3M↓367% | $1.3M↑91% | $655.0K | -- |
| EPS (Diluted) | -- | $-0.21↓450% | $-0.23↓2200% | $-0.08↓300% | $0.07↑137% | $-0.19↓338% | $0.08↑300% | $-0.04 | -- |
| Gross Margin | 20.2%↓14% | 25.5%↑16% | 23.4%↓11% | 24.1%↓13% | 21.2%↑6% | 20.0%↓11% | 22.5%↑14% | 19.7% | — |
| Operating Margin | -7.6%↓964% | -9.5%↓392% | -4.9%↓327% | 0.7%↓88% | -1.0%↑78% | -4.7%↓3185% | 0.2%↑108% | -2.0% | — |
| ROE | -155.9%↓1311% | — | — | — | 10.0%↑131% | -31.8%↓113% | 238.8%↑365% | -90.0% | — |
| Total Debt | $2.6M↓69% | $2.6M↓69% | $2.6M↓83% | $2.6M↑2% | $5.6M↑120% | $2.6M↓13% | $2.9M↓11% | $3.3M | -- |
| Shareholders' Equity | $7.7M↓36% | $7.7M↓36% | $11.6M↑6% | $10.1M↓10% | $11.7M↑11% | $10.5M↑1902% | $524.3K↑172% | -$727.5K↓279% | -$192.0K |
| Current Ratio | 0.67↑17% | 0.67↑17% | 0.77↑61% | 0.58↑30% | 0.57↑17% | 0.49↓51% | 0.99↓18% | 1.20 | — |
| Debt / Equity | 0.33↓52% | 0.33↓52% | 0.22↓84% | 0.26↑13% | 0.48↑98% | 0.24↓96% | 5.59↑223% | -4.53 | — |
| Operating Cash Flow | -$718.2K↓119% | $1.5M↓8% | -$1.7M↓254% | $1.1M↓70% | $4.8M↑236% | -$3.5M↓824% | $484.2K↓67% | $1.5M | -- |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | $434.8K↓70% | $1.4M | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Retail
MSS vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COSTCO WHOLESALE CORP /NEWCOST | $490.2B | $1106.21 | $275.2B | $8.1B | 27.8% | 0.20 | 3.8% | 1.03 | 2/9 | 5/9 | 6/7 | 1/3 | F-Score 6 | 3/11 |
| HOME DEPOT, INC.HD | $347.9B | $348.69 | $164.7B | $14.2B | 110.5% | 4.00 | 12.7% | 1.06 | 3/9 | 5/9 | 3/7 | 1/3 | F-Score 4 | 3/11 |
| TJX COMPANIES INC /DE/TJX | $148.4B | $134.37 | $60.4B | $5.5B | 53.9% | 0.28 | — | 1.14 | 3/9 | 6/9 | 7/7 | 1/3 | F-Score 7 | 4/11 |
| FASTENAL COFAST | $63.3B | $55.19 | $8.2B | $1.3B | 31.9% | 0.03 | 20.2% | 4.85 | 4/9 | 7/9 | 5/7 | 1/3 | F-Score 7 | 5/11 |
| AUTOZONE INCAZO | $52.5B | $3259.70 | $18.9B | $2.5B | -73.2% | -2.61 | 19.1% | 0.88 | 3/9 | 6/9 | 2/7 | 1/3 | F-Score 6 | 4/11 |
| KROGER COKR | $41.8B | $70.80 | $147.6B | $1.0B | 17.1% | 2.68 | 1.3% | 0.80 | 3/9 | 4/9 | 3/7 | 0/3 | F-Score 7 | 3/11 |
| WILLIAMS SONOMA INCWSM | $29.9B | $254.05 | $7.8B | $1.1B | 52.3% | — | 18.1% | 1.39 | 3/9 | 6/9 | 3/7 | 1/3 | F-Score 5 | 3/11 |
| CASEYS GENERAL STORES INCCASY | $26.3B | $712.08 | $17.6B | $714.4M | 18.1% | 0.62 | — | 1.01 | 3/9 | 3/9 | 2/7 | 0/3 | F-Score 9 | 3/11 |